Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts.

Janejira Jaratsittisin Wannapa Sornjai Saovaros Svasti Suthat Fucharoen Sittiruk Roytrakul Duncan R Smith

Published in: Hematology (Amsterdam, Netherlands) (2017)

The in vitro cell system developed here allows further investigation into the processes mediating erythroid cell suppression of liver hepcidin expression in both normal and pathological states.

Keyphrases

poor prognosis
single cell
cell therapy
binding protein
stem cells
bone marrow
sickle cell disease